{"id":"W3023957398","doi":"10.1016/j.clml.2020.04.014","title":"Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the Literature","year":2020,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"Kingston Health Sciences Centre; Hôtel-Dieu de Québec; University of Ottawa; Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto; Université Laval; University of Alberta; Queen's University","funders":"Johnson and Johnson; Alexion Pharmaceuticals; Bristol-Myers Squibb Canada; Gilead Sciences; Sanofi; Amgen Canada; Queen's University; Amgen","keywords":"Medicine; Thrombotic microangiopathy; Carfilzomib; Bortezomib; Multiple myeloma; Proteasome inhibitor; Internal medicine; Dexamethasone; Cyclophosphamide; Melphalan; Oncology; Gastroenterology; Pharmacology; Chemotherapy; Disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003212341,0.0008179083,0.001699741,0.003652591,0.0003790317,0.001141426,0.001041609,0.001308839,0.001707388],"category_scores_gemma":[0.0008983496,0.0002965963,0.0007732563,0.00392843,0.000516975,0.001404527,0.0005246969,0.001118986,0.0006115915],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004261983,"about_ca_system_score_gemma":0.0009769803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001080606,"about_ca_topic_score_gemma":0.002166518,"domain_scores_codex":[0.9997241,0.00003945184,0.00009138617,0.00005561532,0.00006693292,0.0000224489],"domain_scores_gemma":[0.9994319,0.00030711,0.0001490895,0.00001413409,0.0000581868,0.00003960978],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"case_report","study_design_scores_codex":[0.0001985368,0.0001806644,0.005204141,0.04765703,0.0007000382,0.07290882,0.0003483785,0.0006963846,0.003176677,0.00141178,0.03057933,0.8369382],"study_design_scores_gemma":[0.00006735889,0.000298289,0.01411931,0.01981556,0.002155698,0.5448538,0.0006705072,0.000511434,0.001644611,0.001806482,0.4138942,0.0001627974],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006861137,0.9983778,0.000111634,0.0001659659,0.0001183025,0.000004186887,0.00001996892,0.000005499089,0.0005104634],"genre_scores_gemma":[0.004899868,0.9939491,0.0002743303,0.0002427758,0.0003763326,0.000003922325,0.00003734489,0.000001756338,0.0002146375],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003652591,"threshold_uncertainty_score":0.005711734,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05581774254767308,"score_gpt":0.3291006389050129,"score_spread":0.2732828963573398,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}